Insider: Smith Hunter C Chief Financial Officer - RHYTHM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 110,512 | 0 | 110,512 |
| Value | $9,738,317.44 | $0.00 | $9,738,317.44 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/19/2026 | DDS | 585 | Direct | COM | $103.28 | $60,420.44 | 110,512 |
| 02/19/2026 | DDS | 1,308 | Direct | COM | $100.27 | $131,152.90 | 113,589 |
| 02/19/2026 | DDS | 1,692 | Direct | COM | $100.92 | $170,754.78 | 111,897 |
| 02/19/2026 | DDS | 800 | Direct | COM | $102.10 | $81,676.08 | 111,097 |
| 02/17/2026 | DDS | 1,200 | Direct | COM | $99.42 | $119,298.00 | 117,266 |
| 02/17/2026 | DDS | 200 | Direct | COM | $100.52 | $20,104.00 | 117,066 |
| 02/17/2026 | DDS | 200 | Direct | COM | $103.84 | $20,768.00 | 114,897 |
| 02/17/2026 | DDS | 900 | Direct | COM | $101.70 | $91,530.00 | 116,166 |
| 02/17/2026 | DDS | 1,069 | Direct | COM | $103.00 | $110,109.57 | 115,097 |
| 02/12/2026 | DDS | 292 | Direct | COM | $96.26 | $28,108.71 | 119,766 |
| 02/12/2026 | DDS | 400 | Direct | COM | $97.67 | $39,068.52 | 119,366 |
| 02/12/2026 | DDS | 800 | Direct | COM | $98.99 | $79,192.48 | 118,566 |
| 02/12/2026 | DDS | 100 | Direct | COM | $100.10 | $10,010.00 | 118,466 |
| 02/11/2026 | DDS | 2,266 | Direct | COM | $98.37 | $222,906.42 | 120,558 |
| 02/11/2026 | DDS | 100 | Direct | COM | $100.85 | $10,085.27 | 120,058 |
| 02/11/2026 | DDS | 400 | Direct | COM | $99.44 | $39,774.72 | 120,158 |
| 02/10/2026 | DDS | 1,913 | Direct | COM | $102.66 | $196,379.78 | 123,624 |
| 02/10/2026 | DDS | 100 | Direct | COM | $104.76 | $10,476.00 | 122,824 |
| 02/10/2026 | DDS | 700 | Direct | COM | $103.68 | $72,573.69 | 122,924 |
| 02/05/2026 | DDS | 3,381 | Direct | COM | $106.06 | $358,599.00 | 125,537 |
| 02/04/2026 | DDS | 1,500 | Direct | COM | $104.74 | $157,115.10 | 130,665 |
| 02/04/2026 | DDS | 747 | Direct | COM | $107.67 | $80,426.05 | 128,918 |
| 02/04/2026 | DDS | 1,000 | Direct | COM | $106.60 | $106,604.00 | 129,665 |
| 08/13/2025 | DDS | 3,477 | Direct | COM | $96.00 | $333,792.00 | 116,915 |
| 08/12/2025 | DDS | 24,611 | Direct | COM | $96.33 | $2,370,831.77 | 116,915 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research